BICYCLE THERAPEUTICS PLC
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
United Kingdom
Business Address
BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE, X0, CB21 6GS
Mailing Address
BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE, X0, CB21 6GS
Phone
011441223261503
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
-$169.03M
Net Income
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 3 Initial insider ownership report | March 25, 2026 | View on SEC |
| 10-K Annual financial report | March 17, 2026 | View on SEC |
| 8-K Current report of material events | March 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 4, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 3, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 3, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 3, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 18, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 4, 2026 | View on SEC |
Material Events
8-K
Strategy Change
March 17, 2026
High Impact
- Bicycle Therapeutics concluded FY2025 with a robust cash position of $350.8 million, projected to fund operations into late 2027.
- Strategic leadership changes, including a new COO with commercial and oncology experience, signal a stronger push towards drug commercialization.
Insider Trading
SELL
6 insiders
13 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.